An EMT-driven alternative splicing program occurs in human breast cancer and modulates cellular phenotype
- 1Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
- 0Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Alternative splicing significantly impacts epithelial-mesenchymal transition (EMT), a key process in cancer. This study identified an EMT splicing signature, revealing its role in cell phenotype changes and potential as a diagnostic marker for breast cancer progression.
Area Of Science
- Molecular Biology
- Cell Biology
- Cancer Research
Background
- Epithelial-mesenchymal transition (EMT) is crucial for embryonic development and cancer progression.
- While transcriptional regulation of EMT is well-studied, the role of alternative splicing remains less understood.
- Comprehensive analysis of splicing changes during EMT is needed to understand its contribution to morphological alterations.
Purpose Of The Study
- To identify and characterize the alternative splicing signature associated with EMT.
- To investigate the regulatory mechanisms and functional consequences of EMT-associated alternative splicing.
- To explore the potential of EMT splicing patterns as diagnostic and prognostic markers in breast cancer.
Main Methods
- Utilized an established cell culture model for EMT induction.
- Performed RNA-sequencing (RNA-Seq) analyses to identify alternative splicing events.
- Validated EMT splicing signatures in human breast cancer cell lines and primary tumor samples.
Main Results
- Identified a distinct alternative splicing signature for EMT, enriched in genes involved in cell phenotype changes (cytoskeleton, cell junctions, migration).
- Found that EMT-associated splicing events are regulated by splicing factors like RBFOX, MBNL, CELF, hnRNP, and ESRP.
- Demonstrated that EMT splicing patterns can classify breast cancer subtypes (basal and luminal) and are present in primary tumors.
- Showed that manipulating splicing factors (ESRP1, RBFOX2) can alter cell morphology and motility, indicating splicing's functional significance in EMT.
Conclusions
- Alternative splicing plays a significant role in driving phenotypic changes during EMT.
- The identified EMT splicing signature is conserved across cell lines and primary tumors, offering potential for diagnostic and prognostic applications in breast cancer.
- Splicing regulation alone can influence critical aspects of EMT-associated cellular changes.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.